Endobronchial lesion due to pulmonary Fusobacterium nucleatum infection in a child

Ahmet H Gedik1, Erkan Cakir, Omer Soysal

  • 1Department of Pediatric Pulmonology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.

Pediatric Pulmonology
|July 23, 2013
PubMed

Insights

Pulmonary Fusobacterium nucleatum infections are rare, causing severe lung issues. This report details the first case of an endobronchial lesion from F. nucleatum infection in a healthy child, highlighting diagnostic challenges.

Area of Science:

  • Microbiology
  • Pulmonology
  • Pediatric Infectious Diseases

Background:

  • Infections caused by Fusobacterium species, particularly Fusobacterium nucleatum, are uncommon.
  • Pulmonary manifestations of F. nucleatum infection can vary from aspiration pneumonia to severe conditions like necrotizing pneumonia, lung abscess, and empyema.
  • Endobronchial lesions due to F. nucleatum are exceptionally rare in pediatric cases and often lead to delayed diagnosis.

Observation:

  • This report presents a unique case of an endobronchial lesion caused by Fusobacterium nucleatum infection.
  • The affected individual was a previously healthy child.
  • The lesion presented as an endobronchial obstruction.

Findings:

  • This is the first documented instance of an endobronchial lesion attributed to pulmonary Fusobacterium nucleatum infection in the medical literature.
  • The case highlights the potential for F. nucleatum to cause unusual endobronchial pathology in pediatric patients.
  • The diagnosis was challenging due to the rarity of this presentation.

Implications:

  • This case underscores the importance of considering rare pathogens like Fusobacterium nucleatum in the differential diagnosis of pediatric endobronchial lesions.
  • Early recognition and diagnosis are crucial for timely and effective treatment of such infections.
  • Further research may be warranted to understand the pathogenesis and clinical spectrum of F. nucleatum endobronchial infections in children.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...